FiercePharma22h
EMA backs Merck’s Welireg, Bayer’s ATTR med and Gilead’s liver drug from $4.3B deal
Merck & Co.’s kidney cancer drug Welireg, Bayer and BridgeBio’s transthyretin amyloid cardiomyopathy (ATTR-CM) therapy, and ...
FiercePharma18h
McKinsey agrees to $650M DOJ settlement over opioid consulting relationship with Purdue Pharma
Disgraced former OxyContin marketer Purdue Pharma is on the hook for billions after agreeing to settle cases that held the ...
FiercePharma22h
Avalere promotes Amar Urhekar, the architect of its new model, to CEO
Avalere Health has moved Amar Urhekar a rung up the corporate la | Avalere Health has moved Amar Urhekar a rung up the ...
FiercePharma1d
Novo Nordisk’s chief scientific officer looks to the future of GLP-1s
GLP-1 agonists have taken the pharma world by storm, and Novo Nordisk has been at the forefront of it all thanks to ...